drugset / Trial / NCT03868059

Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men

NCT03868059 ↗

Phase 3 Completed 138 enrolled Lipocine Inc.
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label, multi-center, single arm study evaluating the blood pressure (BP) changes from baseline (Visit 3) to post-treatment (Visit 5) assessed by ambulatory blood pressure monitoring (ABPM) in LPCN 1021 treated adult hypogonadal male subjects.

Timeline

Start
2018-04-30
Primary completion
2019-02-19
Completion
2019-02-21

Drugs

EvaluationDrugModalityDoseRoute
Subject LPCN 1021 Unknown 225 mg Oral

Indications